Reference no: EM131866960

In recent years, it has become an increasingly popular practice for drug companies to perform their clinical testing of new drugs in foreign countries that might not have the consumer protections or product liability laws present in the United States. Please answer each of the following questions using a theory studied in Module 2 specifically and thoroughly and using examples and facts from the readings and resources.

• Are drug companies that test experimental drugs in foreign countries acting ethically?
• Is American industry at too much risk of lawsuits to remain competitive? Should companies trying to develop drugs be given immunity from lawsuits?
• Is it ethical for companies to decline to sell a useful drug because they can make more money marketing drugs that are more widely needed? Is it ethical for companies to decline to sell a useful drug in a foreign country because they can make more money marketing the drug elsewhere? Do companies have an ethical obligation to make drugs available in poor countries at little or no cost?
• In the last year, the makers of EpiPen have raised the cost of a 2 pack of this life saving injection to over $600. Should drug costs be controlled or regulated?